Sleep Aids - G7 | Statista Market Forecast

Sleep Aids - G7

Highlights

Revenue in the Sleep Aids market amounts to US$3.32bn in 2024. The market is expected to grow annually by 3.62% (CAGR 2024-2029).
In global comparison, most revenue is generated United States (US$2bn in 2024).
In relation to total population figures, per person revenues of US$4.26 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Sleep Aids market in G7 countries has been experiencing significant growth over the past few years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to the development of this market.

Customer preferences in the Sleep Aids market have been shifting towards natural and non-habit forming sleep aids. Consumers are becoming more conscious of the potential side effects and long-term risks associated with traditional sleep aids, leading them to seek out alternative options. This has resulted in a growing demand for natural sleep aids, such as herbal remedies and aromatherapy products.

Trends in the market have also played a role in the development of the Sleep Aids market in G7 countries. One notable trend is the increasing prevalence of sleep disorders and insomnia. Factors such as high stress levels, busy lifestyles, and the use of electronic devices before bed have all contributed to the rise in sleep-related issues.

As a result, there has been a greater need for sleep aids to help individuals achieve a restful night's sleep. Local special circumstances in each G7 country have influenced the development of the Sleep Aids market. For example, in the United States, the prevalence of sleep disorders and the high demand for sleep aids have been driven by factors such as a sedentary lifestyle, long working hours, and a culture that values productivity.

In Japan, where work-life balance is a major concern, there has been a growing demand for sleep aids to help individuals cope with stress and improve sleep quality. Underlying macroeconomic factors have also played a role in the growth of the Sleep Aids market in G7 countries. Economic prosperity and disposable income levels have allowed consumers to prioritize their health and well-being, leading to increased spending on sleep aids.

Additionally, advancements in technology and the rise of e-commerce have made it easier for consumers to access a wide range of sleep aid products, further driving market growth. In conclusion, the Sleep Aids market in G7 countries has been developing due to shifting customer preferences towards natural sleep aids, the increasing prevalence of sleep disorders, local special circumstances in each country, and underlying macroeconomic factors. As the importance of sleep and overall well-being continues to be emphasized, the Sleep Aids market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.